News

Statement by the Board of Directors of Meda in relation to the public offer by Mylan

Mylan N.V., a leading global pharmaceutical company whose ordinary shares (“Mylan Shares”) are traded on the NASDAQ Global Select Market and the Tel Aviv Stock Exchange under the symbol “MYL”, has today announced a public offer to the shareholders of Meda to transfer all of their shares in Meda to Mylan for a consideration consisting of a combination of cash and Mylan Shares (the “Offer”). Mylan is offering each Meda shareholder.

Read more

Armolipid PLUS

Armolipid PLUS was launched in January 2016

Read more

CB12 Boost Eucalyptus

In November 2015 Meda Health Sales launched a new CB12 Boost chewing gum, CB12 Boost Eucalyptus.

  • Supplement to CB12 mouth wash
  • Helps whiten your teeth
  • ...

Read more

EndWarts PEN

The EndWarts PEN was launched in May 2015.

Read more

CB12 Toothpaste

In April 2015, Meda Health Sales launched CB12 Toothpaste.

Read more

CB12 500ml

Meda Health Sales, in June 2014, launched the new 500ml bottle of CB12 oral rinse. This retails at €19.99 and is a further development of the CB12...

Read more

CB12 Boost

In March 2014 Meda Health Sales launched a new product in the CB12 range, CB12 Boost Chewing Gum.

  • Supplement to CB12 mouth wash
  • Sugar free chewing gum
  • ...

Read more

Irish Managing Director appointed in the UK as Managing Director

Owen McKeon, Country Manager, Ireland & UK

Read more

New CB12 products

Meda Health Sales extended their range of CB12 products by introducing CB12 250ml Oral Rinse Mild and CB12 50ml Oral Rinse (Travel Size).

Read more

Endwarts

Meda launched Endwarts; a new OTC treatment for warts and verrucas.

The active ingredient is Formic Acid and the product is available in all...

Read more

Archive

Categories

Popular topics

This website is intended for people seeking information on Meda Health Sales Ireland. The product information provided in this site is intended for residents of Ireland only.
We also have country specific marketing websites. Links to these are under Meda Worldwide at the top of the page.